NO20012308L - Kombinasjon av riluzol og alfatokoferol - Google Patents

Kombinasjon av riluzol og alfatokoferol

Info

Publication number: NO20012308L
Authority: NO; Norway
Prior art keywords: combination; riluzole; alphatocopherol; benzothiazole; trifluoromethoxy
Prior art date: 1998-11-13

Application number

NO20012308A

Other languages

English (en)

Other versions

NO328349B1 (no

NO20012308D0 (no

Inventor

Michel Dib

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-13

Filing date

2001-05-10

Publication date

2001-05-10

2001-05-10 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2001-05-10 Publication of NO20012308L publication Critical patent/NO20012308L/no

2001-05-10 Publication of NO20012308D0 publication Critical patent/NO20012308D0/no

2010-02-01 Publication of NO328349B1 publication Critical patent/NO328349B1/no

Links

GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 title abstract 4
FTALBRSUTCGOEG-UHFFFAOYSA-N Riluzole Chemical compound C1=C(OC(F)(F)F)C=C2SC(N)=NC2=C1 FTALBRSUTCGOEG-UHFFFAOYSA-N 0.000 title abstract 3
229940087168 alpha tocopherol Drugs 0.000 title abstract 2
229960004181 riluzole Drugs 0.000 title abstract 2
229960000984 tocofersolan Drugs 0.000 title abstract 2
239000002076 α-tocopherol Substances 0.000 title abstract 2
235000004835 α-tocopherol Nutrition 0.000 title abstract 2
239000002671 adjuvant Substances 0.000 abstract 1
239000003085 diluting agent Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Fats And Perfumes (AREA)
External Artificial Organs (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Anti-Oxidant Or Stabilizer Compositions (AREA)
Medicines Containing Plant Substances (AREA)
Plural Heterocyclic Compounds (AREA)
Saccharide Compounds (AREA)
Treatment Of Liquids With Adsorbents In General (AREA)
Cosmetics (AREA)
Pyrane Compounds (AREA)

NO20012308A 1998-11-13 2001-05-10 Kombinasjon av riluzol og α-tokoferol, anvendelse av denne og et farmasoytisk preparat omfattende en slik kombinasjon NO328349B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9814250A FR2785808B1 (fr)	1998-11-13	1998-11-13	Association riluzole et alpha-tocopherol
PCT/FR1999/002753 WO2000028992A1 (fr)	1998-11-13	1999-11-09	Association riluzole et alpha-tocopherol

Publications (3)

Publication Number	Publication Date
NO20012308L true NO20012308L (no)	2001-05-10
NO20012308D0 NO20012308D0 (no)	2001-05-10
NO328349B1 NO328349B1 (no)	2010-02-01

Family

ID=9532674

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20012308A NO328349B1 (no)	1998-11-13	2001-05-10	Kombinasjon av riluzol og α-tokoferol, anvendelse av denne og et farmasoytisk preparat omfattende en slik kombinasjon

Country Status (23)

Country	Link
US (2)	US6642262B2 (no)
EP (1)	EP1128829B1 (no)
JP (1)	JP4693241B2 (no)
KR (1)	KR100641472B1 (no)
CN (1)	CN1177587C (no)
AT (1)	ATE295168T1 (no)
AU (1)	AU776242B2 (no)
BR (1)	BR9915292A (no)
CA (1)	CA2350671C (no)
CZ (1)	CZ298808B6 (no)
DE (1)	DE69925301T2 (no)
DK (1)	DK1128829T3 (no)
EA (1)	EA003671B1 (no)
ES (1)	ES2239858T3 (no)
FR (1)	FR2785808B1 (no)
HK (1)	HK1041220B (no)
HU (1)	HU226067B1 (no)
IL (1)	IL142708A0 (no)
NO (1)	NO328349B1 (no)
PT (1)	PT1128829E (no)
TR (1)	TR200101346T2 (no)
WO (1)	WO2000028992A1 (no)
ZA (1)	ZA200103810B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2786101B1 (fr) *	1998-11-24	2002-07-05	Aventis Laboratoire	Utilisation de la nicergoline dans le traitement de la spasticite
CA2625341A1 (en) *	2005-10-18	2007-04-26	Ono Pharmaceutical Co., Ltd.	Pharmaceutical for protection of motor nerve in patient with amyotrophic lateral sclerosis
US20070099156A1 (en) *	2005-10-28	2007-05-03	Jeff Wagner	Self-etching dental primer compositions and methods and systems utilizing such compositions
FR2957077B1 (fr)	2010-03-02	2012-04-13	Univ Dauvergne Clermont I	Utilisation du riluzole pour traiter ou prevenir les effets indesirables d'agents anti-cancereux
WO2014145776A2 (en) *	2013-03-15	2014-09-18	Baylor College Of Medicine	Msp and its receptors in the therapy of amyotrophic lateral sclerosis
CN114344297B (zh) *	2022-03-01	2024-05-14	暨南大学	利鲁唑在治疗少精症中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2688138B1 (fr) *	1992-03-06	1995-05-05	Rhone Poulenc Rorer Sa	Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la sclerose laterale amyotrophique.
US5843641A (en) *	1993-02-26	1998-12-01	Massachusetts Institute Of Technology	Methods for the daignosis, of familial amyotrophic lateral sclerosis
US6380252B1 (en) *	1996-07-05	2002-04-30	Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.	Use of L-acetylcarnitine, L-isovalerylcarnitine, L-propionylcarnitine for increasing the levels of IGF-1
US5780489A (en) *	1996-08-21	1998-07-14	Brooks; Benjamin Rix	Method for treating amyotrophic lateral sclerosis
JP3889844B2 (ja) *	1997-02-10	2007-03-07	龍兒梶	筋萎縮性側索硬化症治療剤
FR2782008B1 (fr) *	1998-08-07	2003-04-25	Sod Conseils Rech Applic	Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sclerose laterale amyotrophique

1998
- 1998-11-13 FR FR9814250A patent/FR2785808B1/fr not_active Expired - Fee Related
1999
- 1999-11-09 KR KR1020017005912A patent/KR100641472B1/ko not_active Expired - Fee Related
- 1999-11-09 EA EA200100530A patent/EA003671B1/ru not_active IP Right Cessation
- 1999-11-09 CN CNB998131903A patent/CN1177587C/zh not_active Expired - Fee Related
- 1999-11-09 AT AT99972101T patent/ATE295168T1/de active
- 1999-11-09 BR BR9915292-4A patent/BR9915292A/pt not_active Application Discontinuation
- 1999-11-09 TR TR2001/01346T patent/TR200101346T2/xx unknown
- 1999-11-09 HU HU0105301A patent/HU226067B1/hu not_active IP Right Cessation
- 1999-11-09 CA CA2350671A patent/CA2350671C/fr not_active Expired - Fee Related
- 1999-11-09 ES ES99972101T patent/ES2239858T3/es not_active Expired - Lifetime
- 1999-11-09 WO PCT/FR1999/002753 patent/WO2000028992A1/fr not_active Ceased
- 1999-11-09 PT PT99972101T patent/PT1128829E/pt unknown
- 1999-11-09 EP EP99972101A patent/EP1128829B1/fr not_active Expired - Lifetime
- 1999-11-09 HK HK02102998.6A patent/HK1041220B/zh not_active IP Right Cessation
- 1999-11-09 JP JP2000582039A patent/JP4693241B2/ja not_active Expired - Fee Related
- 1999-11-09 DE DE69925301T patent/DE69925301T2/de not_active Expired - Lifetime
- 1999-11-09 CZ CZ20011561A patent/CZ298808B6/cs not_active IP Right Cessation
- 1999-11-09 DK DK99972101T patent/DK1128829T3/da active
- 1999-11-09 IL IL14270899A patent/IL142708A0/xx not_active IP Right Cessation
- 1999-11-09 AU AU11655/00A patent/AU776242B2/en not_active Ceased
2001
- 2001-05-10 ZA ZA200103810A patent/ZA200103810B/en unknown
- 2001-05-10 NO NO20012308A patent/NO328349B1/no not_active IP Right Cessation
- 2001-05-11 US US09/854,318 patent/US6642262B2/en not_active Expired - Lifetime
2003
- 2003-02-18 US US10/369,151 patent/US20030125363A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2350671A1 (fr)	2000-05-25
US6642262B2 (en)	2003-11-04
AU1165500A (en)	2000-06-05
PT1128829E (pt)	2005-07-29
CA2350671C (fr)	2010-05-04
ZA200103810B (en)	2002-08-12
DK1128829T3 (da)	2005-08-29
HUP0105301A3 (en)	2006-07-28
TR200101346T2 (tr)	2002-05-21
DE69925301T2 (de)	2006-01-26
NO328349B1 (no)	2010-02-01
CZ20011561A3 (cs)	2001-08-15
HU226067B1 (en)	2008-04-28
US20030125363A1 (en)	2003-07-03
HK1041220A1 (en)	2002-07-05
HK1041220B (zh)	2005-07-22
AU776242B2 (en)	2004-09-02
CN1326348A (zh)	2001-12-12
DE69925301D1 (de)	2005-06-16
FR2785808B1 (fr)	2002-12-06
EP1128829B1 (fr)	2005-05-11
US20020019426A1 (en)	2002-02-14
CN1177587C (zh)	2004-12-01
BR9915292A (pt)	2001-08-07
ATE295168T1 (de)	2005-05-15
HUP0105301A2 (hu)	2002-05-29
WO2000028992A1 (fr)	2000-05-25
JP4693241B2 (ja)	2011-06-01
EA003671B1 (ru)	2003-08-28
FR2785808A1 (fr)	2000-05-19
CZ298808B6 (cs)	2008-02-06
KR20010080407A (ko)	2001-08-22
JP2002529506A (ja)	2002-09-10
EA200100530A1 (ru)	2001-10-22
NO20012308D0 (no)	2001-05-10
ES2239858T3 (es)	2005-10-01
EP1128829A1 (fr)	2001-09-05
KR100641472B1 (ko)	2006-10-31
IL142708A0 (en)	2002-03-10

Legal Events

Date	Code	Title	Description
2014-06-23	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
NO954427D0 (no)	1995-11-06	Hiv-proteaseinhibitorer som er anvendbare for behandling av AIDS
DK1214936T3 (da)	2004-12-06	Anvendelse af thiazolidin- eller pyrrolidinderivater af aminosyrer som antihyperglykæmiske midler
DK0797439T3 (da)	2003-08-25	Anvendelse af pramipexol som et neurobeskyttende middel
GB9801690D0 (en)	1998-03-25	Therapeutic agents
NO912630L (no)	1992-01-06	Fremgangsmaate for fremstilling av nye 2,6-dialkyl-4-silyl-fenoler som antiarteriosklerotiske midler
NO992492L (no)	1999-05-25	Benzamidoaldehyder og deres anvendelse som cystein-protease-inhibitorer
DK1468689T3 (da)	2007-08-13	2-methyl-thieno-benzodiazepine formulation
FI955721A7 (fi)	1995-11-27	Urokinaasityyppisen plasminogeenin aktivaattorin inhibiittoreiden ilme ntämiseksi
NO20012308L (no)	2001-05-10	Kombinasjon av riluzol og alfatokoferol
FI964342A0 (fi)	1996-10-28	Halogeenimetyyliamideja IL-1beta-proteaasi-inhibiittoreina
ATE211719T1 (de)	2002-01-15	Korrosionsinhibitoren enthaltender injektionszement
AU2002218337A1 (en)	2002-06-11	Method for inducing cognition enhancement by use of trimethyl-bicyclo(2.2.1)heptane derivatives
ID18951A (id)	1998-05-28	Berbagai penggunaan sambungan tap untuk alat penghampar-angkat
UA26459C2 (uk)	1999-08-30	Іhгібітор впливу амілоїдhих білків
SE9704770D0 (sv)	1997-12-19	New use
FI944280L (fi)	1995-03-17	Mingreenin vastaisia indolyylialkyyli-pyridinyyli- ja-pyrimidinyyli-piperatsiinien syklobuteenidionijohdannaisia
AU6206698A (en)	1998-07-31	Isoflavone derivatives, processes for the preparation thereof and pharmac euticalcompositions containing them
CY1107343T1 (el)	2012-12-19	ΕΝΑ ΠΡΟΪΟΝ ΣΥΝΔΥΑΣΜΟΥ ΠΟΥ ΠEPΙΛΑΜΒΑΝΕΙ ΜΕΛΑΓΑΤΡΑΝΗ ΚΑΙ ΕΝΑΝ ΑΝΑΣΤΟΛΕΑ ΠΑΡΑΓΟΝΤΑ VIIa
MY140504A (en)	2009-12-31	Statin-mmp inhibitor combinations
NO905003D0 (no)	1990-11-19	Fremgangsmaate for fremstilling av proteaseinhibitorer frapotetsaft.
FR2778102B1 (fr)	2001-04-06	Utilisation d'oligomeres procyanidoliques (opc) ou d'anthocyanosides a titre d'agents anti-urease
DK0828483T3 (da)	2003-05-19	Anvendelse af tropolonderivater som inhibitorer af enzymet inositolmonophosphatase
SE9303060L (sv)	1995-03-20	Löstagbar stoppanordning
SE9302990L (sv)	1995-03-16	Anordning vid markberedning
IT1303825B1 (it)	2001-02-23	Corredo di strumenti per microchirurgia oftalmica.